Karachi: Citi Pharma Limited has officially announced the departure of Mrs. Farzin Khan from its board of directors. This change in leadership is effective as of June 5, 2025. The company has communicated this update to the TRE Certificate Holders of the Exchange, underscoring a significant shift in its governance structure.

According to information available from the Pakistan Stock Exchange (PSX), Citi Pharma Limited is categorized within the pharmaceutical sector, which regularly updates its stakeholders on boardroom changes and other strategic decisions. The announcement reflects the company’s commitment to maintaining transparency in its operations.

The departure of Mrs. Khan marks a notable change for the company, which has not yet disclosed any further details regarding her successor or any potential restructuring plans. Citi Pharma Limited’s communication to the TRE Certificate Holders remains focused on ensuring that all pertinent updates are disseminated promptly and accurately.